tazverik
Tazverik (Tazemetostat Hydrobromide) is a methyltransferase inhibitor used to treat Sarcoma.
Tazemetostat Hydrobromide · by Epizyme Inc
Key facts
- Active ingredient
- Tazemetostat Hydrobromide
- Drug class
- Methyltransferase Inhibitor
- Form
- Tablet
- Strength
- Tazemetostat Hydrobromide 200MG
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- sarcoma
- Manufacturer
- Epizyme Inc
- FDA application
- NDA213400
Drug class
May treat (source: NIH RxClass)
Dosage forms
Tablet
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Tazverik treat?
- Tazverik (Tazemetostat Hydrobromide) may be used to treat sarcoma, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- Is there a coupon or discount for Tazverik?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Tazverik. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Tazverik?
- Tazverik is marketed by Epizyme Inc. You can see Epizyme Inc's full profile, rating, and other products on pharmaranks.
- Is Tazverik a brand-name or generic drug?
- Tazverik is a brand-name product with the active ingredient Tazemetostat Hydrobromide.
- Is Tazverik available over the counter?
- No. Tazverik is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Tazverik come in?
- Tazverik is currently marketed as tablet, per the FDA's National Drug Code Directory.
- What class of drug is Tazverik?
- Tazverik is classified as methyltransferase inhibitor, per the FDA's Established Pharmacologic Class.
- Is Tazverik FDA-registered?
- Tazverik is on record with the U.S. FDA under application number NDA213400. You can verify this on its official FDA label.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about TAZEMETOSTAT HYDROBROMIDE
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 21 reports naming TAZEMETOSTAT HYDROBROMIDE — the active ingredient in Tazverik, and the FDA flagged 95% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- general physical health deterioration3 reports
- diarrhoea2 reports
- lymphadenopathy2 reports
- pneumonia2 reports
- pulmonary hypertension2 reports
- abdominal discomfort1 reports
- acute abdomen1 reports
- acute myeloid leukaemia1 reports
Read these as a signal, not a rate. A report does not mean TAZEMETOSTAT HYDROBROMIDE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 26, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
Compare Tazverik head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
tazverik
New